Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2014-09, Vol.25, p.v1 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | v1 |
| container_title | Annals of oncology |
| container_volume | 25 |
| creator | Machiels, J-P. Haddad, R.I. Fayette, J. Licitra, L.F. Tahara, M. Vermorken, J.B. Clement, P.M. Gauler, T. Cupissol, D. Grau, J.J. Guigay, J. Caponigro, F. De Castro, G. De Souza Viana, L. Keilholz, U. Del Campo, J.M. Cong, X.J. Svensson, L. Ehrnrooth, E. Cohen, E.E.W. |
| description | |
| doi_str_mv | 10.1093/annonc/mdu438.30 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdu438_30</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdu438_30</sourcerecordid><originalsourceid>FETCH-LOGICAL-c880-4ff2ce482056f64adb361f3e48c5297340e9319ce5a2193c292d006cd6280ff33</originalsourceid><addsrcrecordid>eNotUcGO0zAQDRJILIU7xzmhViJbx06zMbdS7W4rtVDtVnCMZp0xCST2Yjui_XscwsmjeeP33sxLkvcZu86YFEs0xhq17OshF-W1YC-TKya5SG9WIn-dvPH-J2OskFxevZitNYbWtE_wjZwfPBwoNDY4OmMgmB_CeQFrD4-krKnTfWsITo4w9GQCaOvgGL_H2sOfNjTwQGpwbsTQ1MsIRzr0Ic4omD8sDwvYEtYjCF9I_YLH3wP2NspuqOtgg061xvYI863xSi3ge2Ph6OwPR95TDWsdKEp2o-WhTz_j2Dw15PD58ikOtj26C9xq3SpUl-jGD120ZjXsh3P6T_rDJJx9BIRjEwlgt9vFnVrs3iavNHae3v1_Z8np7va02ab7r_e7zXqfqrJkaa41V5SXnK0KXeRYP4ki0yJ21IrLG5EzkiKTilbIMykUl7yO11Z1wUumtRCzhE20ylnvHenqeTJeZawa86um_Kopv0ow8RcxuZPP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Machiels, J-P. ; Haddad, R.I. ; Fayette, J. ; Licitra, L.F. ; Tahara, M. ; Vermorken, J.B. ; Clement, P.M. ; Gauler, T. ; Cupissol, D. ; Grau, J.J. ; Guigay, J. ; Caponigro, F. ; De Castro, G. ; De Souza Viana, L. ; Keilholz, U. ; Del Campo, J.M. ; Cong, X.J. ; Svensson, L. ; Ehrnrooth, E. ; Cohen, E.E.W.</creator><creatorcontrib>Machiels, J-P. ; Haddad, R.I. ; Fayette, J. ; Licitra, L.F. ; Tahara, M. ; Vermorken, J.B. ; Clement, P.M. ; Gauler, T. ; Cupissol, D. ; Grau, J.J. ; Guigay, J. ; Caponigro, F. ; De Castro, G. ; De Souza Viana, L. ; Keilholz, U. ; Del Campo, J.M. ; Cong, X.J. ; Svensson, L. ; Ehrnrooth, E. ; Cohen, E.E.W.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdu438.30</identifier><language>eng</language><ispartof>Annals of oncology, 2014-09, Vol.25, p.v1</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c880-4ff2ce482056f64adb361f3e48c5297340e9319ce5a2193c292d006cd6280ff33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Machiels, J-P.</creatorcontrib><creatorcontrib>Haddad, R.I.</creatorcontrib><creatorcontrib>Fayette, J.</creatorcontrib><creatorcontrib>Licitra, L.F.</creatorcontrib><creatorcontrib>Tahara, M.</creatorcontrib><creatorcontrib>Vermorken, J.B.</creatorcontrib><creatorcontrib>Clement, P.M.</creatorcontrib><creatorcontrib>Gauler, T.</creatorcontrib><creatorcontrib>Cupissol, D.</creatorcontrib><creatorcontrib>Grau, J.J.</creatorcontrib><creatorcontrib>Guigay, J.</creatorcontrib><creatorcontrib>Caponigro, F.</creatorcontrib><creatorcontrib>De Castro, G.</creatorcontrib><creatorcontrib>De Souza Viana, L.</creatorcontrib><creatorcontrib>Keilholz, U.</creatorcontrib><creatorcontrib>Del Campo, J.M.</creatorcontrib><creatorcontrib>Cong, X.J.</creatorcontrib><creatorcontrib>Svensson, L.</creatorcontrib><creatorcontrib>Ehrnrooth, E.</creatorcontrib><creatorcontrib>Cohen, E.E.W.</creatorcontrib><title>Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNotUcGO0zAQDRJILIU7xzmhViJbx06zMbdS7W4rtVDtVnCMZp0xCST2Yjui_XscwsmjeeP33sxLkvcZu86YFEs0xhq17OshF-W1YC-TKya5SG9WIn-dvPH-J2OskFxevZitNYbWtE_wjZwfPBwoNDY4OmMgmB_CeQFrD4-krKnTfWsITo4w9GQCaOvgGL_H2sOfNjTwQGpwbsTQ1MsIRzr0Ic4omD8sDwvYEtYjCF9I_YLH3wP2NspuqOtgg061xvYI863xSi3ge2Ph6OwPR95TDWsdKEp2o-WhTz_j2Dw15PD58ikOtj26C9xq3SpUl-jGD120ZjXsh3P6T_rDJJx9BIRjEwlgt9vFnVrs3iavNHae3v1_Z8np7va02ab7r_e7zXqfqrJkaa41V5SXnK0KXeRYP4ki0yJ21IrLG5EzkiKTilbIMykUl7yO11Z1wUumtRCzhE20ylnvHenqeTJeZawa86um_Kopv0ow8RcxuZPP</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Machiels, J-P.</creator><creator>Haddad, R.I.</creator><creator>Fayette, J.</creator><creator>Licitra, L.F.</creator><creator>Tahara, M.</creator><creator>Vermorken, J.B.</creator><creator>Clement, P.M.</creator><creator>Gauler, T.</creator><creator>Cupissol, D.</creator><creator>Grau, J.J.</creator><creator>Guigay, J.</creator><creator>Caponigro, F.</creator><creator>De Castro, G.</creator><creator>De Souza Viana, L.</creator><creator>Keilholz, U.</creator><creator>Del Campo, J.M.</creator><creator>Cong, X.J.</creator><creator>Svensson, L.</creator><creator>Ehrnrooth, E.</creator><creator>Cohen, E.E.W.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201409</creationdate><title>Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial</title><author>Machiels, J-P. ; Haddad, R.I. ; Fayette, J. ; Licitra, L.F. ; Tahara, M. ; Vermorken, J.B. ; Clement, P.M. ; Gauler, T. ; Cupissol, D. ; Grau, J.J. ; Guigay, J. ; Caponigro, F. ; De Castro, G. ; De Souza Viana, L. ; Keilholz, U. ; Del Campo, J.M. ; Cong, X.J. ; Svensson, L. ; Ehrnrooth, E. ; Cohen, E.E.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c880-4ff2ce482056f64adb361f3e48c5297340e9319ce5a2193c292d006cd6280ff33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machiels, J-P.</creatorcontrib><creatorcontrib>Haddad, R.I.</creatorcontrib><creatorcontrib>Fayette, J.</creatorcontrib><creatorcontrib>Licitra, L.F.</creatorcontrib><creatorcontrib>Tahara, M.</creatorcontrib><creatorcontrib>Vermorken, J.B.</creatorcontrib><creatorcontrib>Clement, P.M.</creatorcontrib><creatorcontrib>Gauler, T.</creatorcontrib><creatorcontrib>Cupissol, D.</creatorcontrib><creatorcontrib>Grau, J.J.</creatorcontrib><creatorcontrib>Guigay, J.</creatorcontrib><creatorcontrib>Caponigro, F.</creatorcontrib><creatorcontrib>De Castro, G.</creatorcontrib><creatorcontrib>De Souza Viana, L.</creatorcontrib><creatorcontrib>Keilholz, U.</creatorcontrib><creatorcontrib>Del Campo, J.M.</creatorcontrib><creatorcontrib>Cong, X.J.</creatorcontrib><creatorcontrib>Svensson, L.</creatorcontrib><creatorcontrib>Ehrnrooth, E.</creatorcontrib><creatorcontrib>Cohen, E.E.W.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machiels, J-P.</au><au>Haddad, R.I.</au><au>Fayette, J.</au><au>Licitra, L.F.</au><au>Tahara, M.</au><au>Vermorken, J.B.</au><au>Clement, P.M.</au><au>Gauler, T.</au><au>Cupissol, D.</au><au>Grau, J.J.</au><au>Guigay, J.</au><au>Caponigro, F.</au><au>De Castro, G.</au><au>De Souza Viana, L.</au><au>Keilholz, U.</au><au>Del Campo, J.M.</au><au>Cong, X.J.</au><au>Svensson, L.</au><au>Ehrnrooth, E.</au><au>Cohen, E.E.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial</atitle><jtitle>Annals of oncology</jtitle><date>2014-09</date><risdate>2014</risdate><volume>25</volume><spage>v1</spage><pages>v1-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdu438.30</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2014-09, Vol.25, p.v1 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdu438_30 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A13%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Afatinib%20Versus%20Methotrexate%20(Mtx)%20As%20Second-Line%20Treatment%20for%20Patients%20with%20Recurrent%20and/or%20Metastatic%20(R/M)%20Head%20and%20Neck%20Squamous%20Cell%20Carcinoma%20(Hnscc)%20Who%20Progressed%20After%20Platinum-Based%20Therapy:%20Primary%20Efficacy%20Results%20of%20Lux-Head%20&%20Neck%201,%20a%20Phase%20III%20Trial&rft.jtitle=Annals%20of%20oncology&rft.au=Machiels,%20J-P.&rft.date=2014-09&rft.volume=25&rft.spage=v1&rft.pages=v1-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdu438.30&rft_dat=%3Ccrossref%3E10_1093_annonc_mdu438_30%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |